| Dr Andrea L Stephens, MD | |
|
226 S Woods Mill Rd, Ste 55w, Chesterfield, MO 63017-3662 | |
| (314) 542-4953 | |
| (314) 590-5942 |
| Full Name | Dr Andrea L Stephens |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 36 Years |
| Location | 226 S Woods Mill Rd, Chesterfield, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447276670 | NPI | - | NPPES |
| 203102710 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | R3P80 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Lukes Hospital | Chesterfield, MO | Hospital |
| Missouri Baptist Medical Center | Town and country, MO | Hospital |
| Barnes Jewish Hospital | Saint louis, MO | Hospital |
| Entity Name | Physician Groups Lc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285664268 PECOS PAC ID: 3072421254 Enrollment ID: O20040220001157 |
News Archive
Researchers from the Japan Advanced Institute of Science and Technology (JAIST) and Ishikawa Prefectural University, Japan, recently attempted to synthesize the ORF8 protein with the help of a chemical-inducible protein production system using tobacco BY-2 cells. This study has been published demonstrated in the preprint server, bioRxiv.
GlaxoSmithKline plc (GSK) and XenoPort, Inc. announced today that the United States (US) Food and Drug Administration (FDA) has approved Horizant (gabapentin enacarbil) Extended-Release Tablets for the management of postherpetic neuralgia (PHN) in adults.
Research conducted at the University of Adelaide has discovered that bees have much better vision than was previously known, offering new insights into the lives of honey bees, and new opportunities for translating this knowledge into fields such as robot vision.
Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, and FBM Industria Farmaceutica Ltda, a member of the HOSPFAR Group that manufactures, imports and distributes pharmaceuticals in Brazil, today announced a license and distribution agreement providing FMBFarma exclusive rights to market Zertane in Brazil for the treatment of premature ejaculation.
In a new clinical trial, UC Davis Health will test the effectiveness and safety of REGN-COV2, the monoclonal antibody cocktail, in preventing COVID-19 in adults living with infected patients.
› Verified 8 days ago
| Entity Name | Womens Care Of St Lukes Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245791474 PECOS PAC ID: 6507109147 Enrollment ID: O20190522000821 |
News Archive
Researchers from the Japan Advanced Institute of Science and Technology (JAIST) and Ishikawa Prefectural University, Japan, recently attempted to synthesize the ORF8 protein with the help of a chemical-inducible protein production system using tobacco BY-2 cells. This study has been published demonstrated in the preprint server, bioRxiv.
GlaxoSmithKline plc (GSK) and XenoPort, Inc. announced today that the United States (US) Food and Drug Administration (FDA) has approved Horizant (gabapentin enacarbil) Extended-Release Tablets for the management of postherpetic neuralgia (PHN) in adults.
Research conducted at the University of Adelaide has discovered that bees have much better vision than was previously known, offering new insights into the lives of honey bees, and new opportunities for translating this knowledge into fields such as robot vision.
Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, and FBM Industria Farmaceutica Ltda, a member of the HOSPFAR Group that manufactures, imports and distributes pharmaceuticals in Brazil, today announced a license and distribution agreement providing FMBFarma exclusive rights to market Zertane in Brazil for the treatment of premature ejaculation.
In a new clinical trial, UC Davis Health will test the effectiveness and safety of REGN-COV2, the monoclonal antibody cocktail, in preventing COVID-19 in adults living with infected patients.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrea L Stephens, MD 226 S Woods Mill Rd, Ste 55w, Chesterfield, MO 63017-3662 Ph: (314) 542-4953 | Dr Andrea L Stephens, MD 226 S Woods Mill Rd, Ste 55w, Chesterfield, MO 63017-3662 Ph: (314) 542-4953 |
News Archive
Researchers from the Japan Advanced Institute of Science and Technology (JAIST) and Ishikawa Prefectural University, Japan, recently attempted to synthesize the ORF8 protein with the help of a chemical-inducible protein production system using tobacco BY-2 cells. This study has been published demonstrated in the preprint server, bioRxiv.
GlaxoSmithKline plc (GSK) and XenoPort, Inc. announced today that the United States (US) Food and Drug Administration (FDA) has approved Horizant (gabapentin enacarbil) Extended-Release Tablets for the management of postherpetic neuralgia (PHN) in adults.
Research conducted at the University of Adelaide has discovered that bees have much better vision than was previously known, offering new insights into the lives of honey bees, and new opportunities for translating this knowledge into fields such as robot vision.
Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, and FBM Industria Farmaceutica Ltda, a member of the HOSPFAR Group that manufactures, imports and distributes pharmaceuticals in Brazil, today announced a license and distribution agreement providing FMBFarma exclusive rights to market Zertane in Brazil for the treatment of premature ejaculation.
In a new clinical trial, UC Davis Health will test the effectiveness and safety of REGN-COV2, the monoclonal antibody cocktail, in preventing COVID-19 in adults living with infected patients.
› Verified 8 days ago
Dr. Caroline Anne Morgan, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 226 S Woods Mill Rd, Suite 68 West, Chesterfield, MO 63017 Phone: 314-576-0930 Fax: 314-514-8229 | |
Dr. Stephen C Yim, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 226 S Woods Mill Rd, Suite 55 West, Chesterfield, MO 63017 Phone: 314-469-4440 Fax: 314-576-2346 | |
Dr. Laura Irene Moore, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 224 South Woods Mill Road, Suite 750, Chesterfield, MO 63017 Phone: 314-576-9797 Fax: 314-469-7517 | |
Dr. Joe Edward Belew, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 224 S Woods Mill Rd, Suite 750, Chesterfield, MO 63017 Phone: 314-576-9797 Fax: 314-469-7517 | |
Dr. Jessica Baldetti, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 226 S Woods Mill Rd Ste 68w, Chesterfield, MO 63017 Phone: 314-205-6788 Fax: 314-590-5954 | |
Katherine A Maxson, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 226 S Woods Mill Rd, S5w, Chesterfield, MO 63017 Phone: 314-469-0001 | |
Marta I Pineda, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 226 S Woods Mill Rd, Ste 61w, Chesterfield, MO 63017 Phone: 314-205-6957 |